Free Trial

Cosmos Health Q2 2024 Earnings Report

Cosmos Health logo
$0.71 +0.05 (+7.06%)
As of 01/31/2025 04:00 PM Eastern

Cosmos Health EPS Results

Actual EPS
-$0.09
Consensus EPS
-$0.14
Beat/Miss
Beat by +$0.05
One Year Ago EPS
N/A

Cosmos Health Revenue Results

Actual Revenue
$13.21 million
Expected Revenue
$15.25 million
Beat/Miss
Missed by -$2.04 million
YoY Revenue Growth
N/A

Cosmos Health Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Cosmos Health Earnings Headlines

Turning Panic Into Opportunity
AI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intelligence sector. But here's the thing …
See More Cosmos Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cosmos Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cosmos Health and other key companies, straight to your email.

About Cosmos Health

Cosmos Health (NASDAQ:COSM) manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

View Cosmos Health Profile

More Earnings Resources from MarketBeat